LLY compared with DNTH: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

DNTHDianthus Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

DNTHDianthus Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

DNTH

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.7%▲+1.90%×0.20

May 6 '26±7.6%▲+0.20%×0.03

= impliedLLY realized, solidDNTH realized, hatchedOne scale, both sides: full bar = 22%× = |realized| ÷ impliedSource: market data

Q1 FY26

±11.9%

▲+21.52%

×1.81

Jan 12 '26±9.0%▲+2.44%×0.27

LLYELI Lilly & Co

1,417.89▲+0.60%· post 1,418.02· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

DNTHDianthus Therapeutics, Inc.

84.84▲+2.58%· post 85.79· delayed

After hoursNov 4 '26delayed

Mkt cap$4.6BRevenue$761,000Q2 FY26Revenue$6MFY24

Compare

After hoursNov 4 '26delayed

LLYELI Lilly & Co

DNTHDianthus Therapeutics, Inc.

1,417.89▲+0.60%post 1,418.02delayed

Price

84.84▲+2.58%post 85.79delayed

$1.3T

Mkt cap

$4.6B

Q3 FY26$24.4B

Revenue

$761,000Q2 FY26

FY25$65.2B

Revenue

$6MFY24

LLY1,417.89▲+0.60%vsDNTH84.84▲+2.58%After hoursNov 4 '26delayed